SCHEMBL12232115

SCHEMBL12232115

c1cncc(-c2cc(-c3cccnc3)cc(-c3cc(-c4nc5ccccc5o4)cc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)n3)c2)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.72
HSD17B10 Q99714 5/20 0.72
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
CYP19A1 P11511 1/20 0.54
KDM4E B2RXH2 8/20 0.53
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
CYP1A2 P05177 4/20 0.53
CYP2C19 P33261 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
HPGD P15428 4/20 0.53
CYP3A4 P08684 2/20 0.53
TP53 P04637 2/20 0.53
CYP2C9 P11712 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
HTT P42858 1/20 0.53
CYP2D6 P10635 1/20 0.53
TSHR P16473 2/20 0.52
POLB P06746 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12232116 0.96 ALDH1A1 (0.69) ALDH1A1HSD17B10MEN1KMT2ACYP19A1
SCHEMBL12232099 0.93 ALDH1A1 (0.82) ALDH1A1HSD17B10MEN1KMT2AKDM4E
SCHEMBL12232113 0.93 ALDH1A1 (0.82) ALDH1A1HSD17B10MEN1KMT2AKDM4E
SCHEMBL12232112 0.93 ALDH1A1 (0.82) ALDH1A1HSD17B10MEN1KMT2AKDM4E
SCHEMBL12231991 0.91 ALDH1A1 (0.78) ALDH1A1HSD17B10MEN1KMT2ACYP19A1
SCHEMBL12231993 0.88 ALDH1A1 (0.74) ALDH1A1HSD17B10MEN1KMT2ACYP19A1
SCHEMBL14225132 0.85 ALDH1A1 (0.51) ALDH1A1HSD17B10MEN1KMT2AKDM4E
SCHEMBL14225130 0.84 ALDH1A1 (0.54) ALDH1A1HSD17B10MEN1KMT2AKDM4E
SCHEMBL11773057 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10MEN1KMT2AKDM4E
SCHEMBL30280651 0.84 ALDH1A1 (1.00) ALDH1A1HSD17B10MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772632-B2 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the same CHEIL INDUSTRIES, INC. (KR) 2014-07-08 US disclosed
US-8772632-B2 Compound for organic photoelectric device, organic photoelectric device including the same, and display device including the same CHEIL INDUSTRIES, INC. (KR) 2014-07-08 US disclosed
US-20130274471-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME IN KYU-YEON (KR) 2013-10-17 US disclosed
US-20130274471-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME IN KYU-YEON (KR) 2013-10-17 US disclosed
US-20110260153-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-10-27 US disclosed
US-20110260153-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110260153-A1 COMPOUND FOR ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE SAME PPOX, AOX1, OR10J3 ALDH1A1 14/4885HSD17B10 608/4885MEN1 2132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.